secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ceribell, Inc. (CBLL)
CIK:        0001861107
Form:       8-K
Filed at:   2025-11-24T23:59:59+00:00
Accession:  0001193125-25-292140
Event type: regulatory
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ceribell receives FDA 510(k) clearance for Clarity algorithm to detect seizures in neonates
--------------------------------------------------------------------------------

- FDA clearance covers use of Clarity algorithm for electrographic seizure detection in newborns preterm and older through adults, the first AI-powered point-of-care EEG for all ages.
- Clearance supported by EEG data from over 700 patients, the largest known validation dataset for a neonatal seizure detection system.
- Approximately 9% of NICU patients may have seizures, but up to 90% go undetected without EEG monitoring, per the release.
- Ceribell previously received 510(k) clearance for a headcap optimized for the neonatal population.
- CEO Jane Chao cited the clearance as expanding availability of rapid, AI-powered neurological monitoring to more patients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861107/000119312525292140/0001193125-25-292140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861107/000119312525292140/cbll-20251124.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-292140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer